Development and validation of a mass spectrometric method to determine the identity of rituximab based on its microheterogeneity profile....

Transcriptome-based identification of lovastatin as a breast cancer stem cell-targeting drug. VER MÁS

Progress and Challenges in the Design and Clinical Development of Antibodies for Cancer Therapy. VER MÁS

Taking advantage of a high-throughput flow cytometer for the implementation of an ADCC assay for regulatory compliance. VER MÁS

Sequencing Analysis and Identification of the Primary Peptide Component of the Dialyzable Leukocyte Extract “Transferon Oral”: The Starting Point...